HHS Hits Back At AstraZeneca's Challenge To Drug Price Rule
The federal government has urged a Delaware federal judge not to block the Inflation Reduction Act's provision allowing it to negotiate drug prices with pharmaceutical companies, arguing that AstraZeneca doesn't have...To view the full article, register now.
Already a subscriber? Click here to view full article